FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: Mettler-Toledo International

Sort
E.g., 2013-05-22
E.g., 2013-05-22
Enter a comma separated list of user names.

EntreMed, Inc. (NASDAQ:ENMD)

EntreMed, Inc. is a clinical-stage pharmaceutical company committed to developing ENMD-2076, a selective angiogenic kinase inhibitor, for the treatment of cancer.

ENMD-2076 is currently in a multi-center Phase 2 study in ovarian cancer and in several Phase 1 studies in solid tumors, multiple myeloma, and leukemia.

ADVERTISE WITH US